108 nations recognise Indian Covid vax certificate for travel purpose: Govt

A total of 108 countries recognise the Indian COVID-19 vaccination certificate for travel purpose, Minister of State for Health Bharati Pravin Pawar informed Lok Sabha on Friday

air travel, flights, passengers, aviation, airlines
Press Trust of India New Delhi
1 min read Last Updated : Dec 10 2021 | 2:31 PM IST

A total of 108 countries recognise the Indian COVID-19 vaccination certificate for travel purpose, Minister of State for Health Bharati Pravin Pawar informed Lok Sabha on Friday, sharing data available as on December 6.

The World Health Organization's Emergency Use Listing (EUL) assists interested UN procurement agencies, member states and countries in determining acceptability of using specific vaccines, based on an essential set of available data on quality, safety, efficacy and performance, Pawar said in a written reply.

The aim is to expedite availability of these products to people affected by a public health emergency, and it allows countries to expedite their own regulatory approval to import and administer COVID-19 vaccines, she said.

Persons inoculated with such vaccines, which are listed under the WHO- EUL, are deemed to be protected by authorities of many countries and allowed to travel internationally, Pawar said.

"However, not all countries require COVID-19 vaccination for travel. India also does not, at present, require COVID-19 vaccination for travel. Among the countries, which do have such requirements, as on 6th December 2021, a total of 108 countries recognise the Indian vaccination certificate for travel purpose," she said in the written reply.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineVaccination

First Published: Dec 10 2021 | 2:31 PM IST

Next Story